U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 210797

Marketing Status: Prescription
Active Ingredient: AFAMELANOTIDE
Proprietary Name: SCENESSE
Dosage Form; Route of Administration: IMPLANT; SUBCUTANEOUS
Strength: 16MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210797
Product Number: 001
Approval Date: Oct 8, 2019
Applicant Holder Full Name: CLINUVEL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top